Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | GRIA2 | P42262 | 6/20 | 0.40 |
| ▸ | GRIA1 | P42261 | 5/20 | 0.40 |
| ▸ | GRIA3 | P42263 | 5/20 | 0.40 |
| ▸ | GRIA4 | P48058 | 5/20 | 0.40 |
| ▸ | PKM | P14618 | 2/20 | 0.39 |
| ▸ | ALPI | P09923 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | XIAP | P98170 | 1/20 | 0.39 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.36 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.36 |
| ▸ | GRIK3 | Q13003 | 2/20 | 0.36 |
| ▸ | GRIK4 | Q16099 | 2/20 | 0.36 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Histidine SCHEMBL3457996 | 1.00 | SLC7A5 (0.43) | SLC7A5CYP3A4CYP1A2GRIA2GRIA1 | |
| Histidine SCHEMBL4610837 | 1.00 | SLC7A5 (0.43) | SLC7A5CYP3A4CYP1A2GRIA2GRIA1 | |
| Histidine SCHEMBL7521151 | 0.94 | SLC7A5 (0.39) | SLC7A5CYP3A4CYP1A2GRIA2GRIA1 | |
| Histidine SCHEMBL20678156 | 0.94 | SLC7A5 (0.39) | SLC7A5CYP3A4CYP1A2GRIA2GRIA1 | |
| Histidine SCHEMBL27615468 | 0.94 | SLC7A5 (0.41) | SLC7A5CYP3A4CYP1A2GRIA2GRIA1 | |
| Histidine SCHEMBL28093403 | 0.94 | SLC7A5 (0.45) | SLC7A5CYP3A4CYP1A2GRIA2GRIA1 | |
| Histidine SCHEMBL3050310 | 0.94 | SLC7A5 (0.49) | SLC7A5CYP3A4CYP1A2GRIA2GRIA1 | |
| Histidine SCHEMBL3050307 | 0.94 | SLC7A5 (0.49) | SLC7A5CYP3A4CYP1A2GRIA2GRIA1 | |
| Histidine SCHEMBL163443 | 0.94 | SLC7A5 (0.47) | SLC7A5CYP3A4CYP1A2GRIA2GRIA1 | |
| Histidine SCHEMBL8080341 | 0.94 | SLC7A5 (0.47) | SLC7A5CYP3A4CYP1A2GRIA2GRIA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0368920-A1 | LECTINES FIXING BETA-D-GALACTOSIDE. | IDEON CORP (US) | 1990-05-23 | — | — | EP | claimed |
| WO-1989000581-A1 | LECTINES FIXING BETA-D-GALACTOSIDE | IDEON CORPORATION (US) | 1989-01-26 | — | — | WO | claimed |
| CN-115746110-A | Mutant of transcriptional regulatory factor LysG and application thereof | 中国科学院天津工业生物技术研究所 | 2023-03-07 | — | — | CN | disclosed |
| CN-115746111-A | Mutant of transcription regulatory factor LysG and application thereof | 中国科学院天津工业生物技术研究所 | 2023-03-07 | — | — | CN | disclosed |
| CN-113795588-A | Methods for scar-free introduction of targeted modifications in targeting vectors | 瑞泽恩制药公司 | 2021-12-14 | — | — | CN | disclosed |
| CN-111743798-A | Multi-effect anti-aging skin care product and preparation method thereof | 合肥卡迪尔生物科技有限公司 | 2020-10-09 | — | — | CN | disclosed |
| CN-111228509-A | Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles | 豪夫迈·罗氏有限公司 | 2020-06-05 | — | — | CN | disclosed |
| CN-105899540-B | Bispecific anti-hapten/anti-blood-brain barrier receptor antibodies, complexes thereof and their use as blood-brain barrier shuttles | 豪夫迈·罗氏有限公司 | 2020-02-07 | — | — | CN | disclosed |
| CN-105985425-B | polyethylene glycol modified exendin analogue and preparation method and application thereof | 浙江海昶生物医药技术有限公司 | 2019-12-17 | — | — | CN | disclosed |
| EP-3314264-A1 | MEANS AND METHODS FOR DIAGNOSING PANCREATIC CANCER IN A SUBJECT BASED ON A BIOMARKER PANEL | Metanomics Health GmbH (DE) | 2018-05-02 | — | — | EP | disclosed |
| WO-2016207391-A1 | MEANS AND METHODS FOR DIAGNOSING PANCREATIC CANCER IN A SUBJECT BASED ON A BIOMARKER PANEL | METANOMICS HEALTH GMBH (DE) | 2016-12-29 | — | — | WO | disclosed |
| WO-2002032450-A2 | VACCINES | GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) | 2002-04-25 | — | — | WO | disclosed |
| EP-1194571-A1 | PROSTASE VACCINE | SMITHKLINE BEECHAM BIOLOGICALS s.a. (BE) | 2002-04-10 | — | — | EP | disclosed |
| WO-2002000867-A1 | PROSTASE PROTEIN VACCINE COMPRISING DERIVATISED THIOL RESIDUES AND METHODS FOR PRODUCING SAID ANTIGEN | GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) | 2002-01-03 | — | — | WO | disclosed |
| WO-2002000708-A2 | MUTANTS OF PROSTASE | SMITHKLINE BEECHAM BIOLOGICALS S.A. (BE) | 2002-01-03 | — | — | WO | disclosed |
| WO-2001004143-A2 | PROSTASE VACCINE | SMITHKLINE BEECHAM BIOLOGICALS S.A. (BE) | 2001-01-18 | — | — | WO | disclosed |
| EP-0772669-A1 | SALINE SOLUTION FOR TREATING CONTACT LENSES | ALCON LABORATORIES, INC. (US) | 1997-05-14 | — | — | EP | disclosed |
| WO-1996003484-A1 | SALINE SOLUTION FOR TREATING CONTACT LENSES | ALCON LABORATORIES, INC. (US) | 1996-02-08 | — | — | WO | disclosed |
| EP-0368920-A1 | LECTINES FIXING BETA-D-GALACTOSIDE. | IDEON CORP (US) | 1990-05-23 | — | — | EP | disclosed |
| WO-1989000581-A1 | LECTINES FIXING BETA-D-GALACTOSIDE | IDEON CORPORATION (US) | 1989-01-26 | — | — | WO | disclosed |